Ocular Therapeutix, Inc. (OCUL) Social Stream
Ocular Therapeutix Inc (OCUL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Ocular Therapeutix Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 21 months, OCUL's average price target has gone up $8.83.
OCUL reports an average of 135% for its upside potential over the past 48 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
OCUL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
OCUL's average broker recommendation rating improved by 0.5 over the prior 15 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Ocular Therapeutix Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 467.38% of that group.
- Ocular Therapeutix Inc's variance in analysts' estimates is lower than -327.77% of all US stocks.
- In the context of stocks in the small market cap category, Ocular Therapeutix Inc's number of analysts covering the stock is greater than 401.23% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, Ocular Therapeutix Inc's average analyst price target is higher than 175.13% of them.
Is OCUL a Buy, Hold or Sell? See the POWR Ratings now!